H.U. Group forecasts higher profit on asset and share sales

H.U. Group Holdings, Inc. announced a revision to its consolidated full-year earnings forecast for the fiscal year ending March 2026, projecting a notable increase in net profit. This upward revision is primarily due to the planned transfer of fixed assets and the sale of shares in Carelex.

The company expects to record extraordinary gains from the sale of land in Kameoka City, Kyoto Prefecture, yielding a profit of JPY 2.3 bn. This decision follows a re-evaluation of its New Kansai Laboratory project due to rising construction costs and a strategic shift toward optimizing lab functions under the H.U.2030 medium-term management plan. Additionally, the sale of an 80% stake in Carelex will generate an extraordinary gain of JPY 4.1 bn. Both transactions are scheduled for the third quarter of the fiscal year ending March 2026.

As a result of these transactions, the revised forecast for the fiscal year ending March 31, 2026, anticipates a net profit attributable to parent company shareholders of JPY 7.0 bn, an increase of JPY 1.5 bn from the previous forecast of JPY 5.5 bn. The earnings per share are now expected to be JPY 124.69, up from JPY 96.80. The company’s sales, operating profit, and ordinary profit forecasts remain unchanged at JPY 252.0 bn, JPY 8.0 bn, and JPY 6.0 bn, respectively.